“Our findings reinforce the importance of RSV vaccination in older adults and suggest that monitoring for signs of heart ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...

Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...